Are you Dr. Cullinan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 31 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
8940 N Wood Sage Rd
Peoria, IL 61615Phone+1 309-243-3000Fax+1 309-243-3050
Summary
- Dr. Stephen Cullinan, MD is an oncologist in Peoria, Illinois. He is currently licensed to practice medicine in Illinois, Tennessee, and Oklahoma. He is affiliated with Carle Health Methodist Hospital.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1975 - 1977
- Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1972 - 1974
- University of Illinois College of MedicineClass of 1972
Certifications & Licensure
- IA State Medical License Active through 2014
- IL State Medical License Active through 2014
- CO State Medical License Active through 2013
- GA State Medical License Active through 2013
- IN State Medical License 2001 - 2013
- KY State Medical License Active through 2013
- MI State Medical License Active through 2013
- Join now to see all
Publications & Presentations
PubMed
- 310 citationsA Comparison of Three Chemotherapeutic Regimens in the Treatment of Advanced Pancreatic and Gastric Carcinoma: Fluorouracil vs Fluorouracil and Doxorubicin vs Fluorour...Stephen A. Cullinan, Charles G. Moertel, Thomas R. Fleming, Joseph Rubin, James E. Krook
JAMA. 1985-04-12 - 59 citationsProspective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)Stuart M. Lichtman, Donna Hollis, Antonius A. Miller, Gary L. Rosner, Chris A. Rhoades
Journal of Clinical Oncology. 2006-04-20 - 167 citationsA phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand, Allan J. Schutt, James E. Krook
Cancer. 1990-05-15